{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T17:10:13Z","timestamp":1756746613314,"version":"3.44.0"},"reference-count":36,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Oulu University Hospital","award":["K74809"],"award-info":[{"award-number":["K74809"]}]},{"name":"Sigrid Juselius Foundation","award":["8149"],"award-info":[{"award-number":["8149"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2024,8,30]]},"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Ocular toxoplasmosis (OT) can cause posterior uveitis; causes of recurrent OT are not well understood. We explored clinical, immunological and genetic properties associated with recurrent OT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>A recurrent OT patient population (n=9) was identified. Clinical history, ophthalmological findings and immunological properties were assessed. B and T cell immunophenotyping including interferon-gamma (IFN-\u03b3) responses were analysed. An analysis of 592 immunodeficiency genes was performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The patients experienced 2\u20137 OT episodes (average 3.7). The first episode occurred at an average of 23.8 (SD 10.1) years of age. All patients had anterior uveitis, vitritis and various fundus lesions of OT. The patients had lymphocyte maturation abnormalities; the proportion of naive CD4<jats:sup>+<\/jats:sup>CD45RA<jats:sup>+<\/jats:sup>CCR7<jats:sup>+<\/jats:sup> T cells was high in 5\/9 cases, and the percentage of CD4<jats:sup>+<\/jats:sup>CD45RA<jats:sup>\u2212<\/jats:sup>CCR7<jats:sup>\u2212<\/jats:sup> T effector memory cells was reduced in 7\/9 cases. An increased percentage of CD19<jats:sup>+<\/jats:sup>CD38<jats:sup>low<\/jats:sup>CD21<jats:sup>low<\/jats:sup> activated B cells was observed in 5\/9 cases. IFN-\u03b3 response was reduced in CD4<jats:sup>+<\/jats:sup> (8.45\u00b14.17 vs 21.27\u00b111.0, p=0.025) and CD8<jats:sup>+<\/jats:sup> (39.0\u00b19.9 vs 18.1\u00b118.1, p=0.017) T cells. Genetic analysis revealed several potentially harmful variants in immunologically active <jats:italic>ERCC3, MANBA, IRF4, HAVCR2, CARMIL2, CD247, MPO, C2<\/jats:italic> and <jats:italic>CD40<\/jats:italic> genes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our recurrent OT cases had deviations in lymphocyte maturation and IFN-\u03b3 responses possibly caused by genetic reasons. However, limitations of our study include failure to identify uniform genetic mechanisms. In addition, we cannot rule out the possibility that the immunological abnormalities can be triggered by chronic toxoplasmosis. Despite the limitations, our findings contribute to the understanding of ocular immunity and development of recurrent OT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-001769","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T01:27:20Z","timestamp":1726450040000},"page":"e001769","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent ocular toxoplasmosis is associated with interferon-gamma deficiency possibly due to genetic origin"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-5602","authenticated-orcid":false,"given":"Nina Maria","family":"Hautala","sequence":"first","affiliation":[{"name":"Research Unit of Clinical Medicine, Department of Ophthalmology, University of Oulu, Oulu, Finland"},{"name":"Department of Ophthalmology, Medical Research Center, Oulu University Hospital, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Joensuu","sequence":"additional","affiliation":[{"name":"Northern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teija","family":"Paakkola","sequence":"additional","affiliation":[{"name":"Northern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3461-6471","authenticated-orcid":false,"given":"Virpi","family":"Glumoff","sequence":"additional","affiliation":[{"name":"Research Unit of Internal Medicine and Biomedicine, University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Kettunen","sequence":"additional","affiliation":[{"name":"HUS Diagnostic Center, Division of Genetics and Clinical Pharmacology, Laboratory of Genetics, HUS Helsinki University Hospital, Helsinki, Finland"},{"name":"HiLIFE, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janna","family":"Saarela","sequence":"additional","affiliation":[{"name":"HiLIFE, Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"},{"name":"Centre for Molecular Medicine, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Siiskonen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Oulu University Hospital, Oulu, Finland"},{"name":"University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[{"name":"Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Pylk\u00e4s","sequence":"additional","affiliation":[{"name":"Northern Finland Laboratory Center Nordlab, NordLab Laboratoriot, Oulu, Finland"},{"name":"Research Unit of Translational Medicine, University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7889-1614","authenticated-orcid":false,"given":"Timo","family":"Hautala","sequence":"additional","affiliation":[{"name":"Research Unit of Internal Medicine and Biomedicine, University of Oulu, Oulu, Finland"},{"name":"ERN-RITA Core Center Member, RITAFIN Consortium, Infectious Diseases Clinic, Oulu University Hospital, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,9,13]]},"reference":[{"key":"2025090109500776000_9.1.e001769.1","doi-asserted-by":"crossref","first-page":"100882","DOI":"10.1016\/j.preteyeres.2020.100882","article-title":"Pathogenesis of ocular toxoplasmosis","volume":"81","author":"Smith","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"2025090109500776000_9.1.e001769.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70532-X"},{"key":"2025090109500776000_9.1.e001769.3","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.354"},{"key":"2025090109500776000_9.1.e001769.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283845","article-title":"Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis","volume":"18","author":"Cifuentes-Gonz\u00e1lez","year":"2023","journal-title":"PLoS One"},{"key":"2025090109500776000_9.1.e001769.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2016.06.053"},{"key":"2025090109500776000_9.1.e001769.6","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.actatropica.2021.106180","article-title":"Ocular toxoplasmosis, an overview focusing on clinical aspects","volume":"225","author":"Fabiani","year":"2022","journal-title":"Acta Trop"},{"key":"2025090109500776000_9.1.e001769.7","doi-asserted-by":"crossref","first-page":"112592","DOI":"10.1016\/j.celrep.2023.112592","article-title":"Host genetics highlights IFN-\u03b3-dependent Toxoplasma genes encoding secreted and non-secreted virulence factors in in vivo CRISPR screens","volume":"42","author":"Tachibana","year":"2023","journal-title":"Cell Rep"},{"key":"2025090109500776000_9.1.e001769.8","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.868727","article-title":"Unifying Virulence Evaluation in Toxoplasma gondii: A Timely Task","volume":"12","author":"Calero-Bernal","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090109500776000_9.1.e001769.9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/09273948.2020.1735450","article-title":"Disease of the Year 2019: Ocular Toxoplasmosis in HIV-infected Patients","volume":"28","author":"de-la-Torre","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090109500776000_9.1.e001769.10","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0196-9"},{"key":"2025090109500776000_9.1.e001769.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211627","article-title":"Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-\u03b3 +874 T\/A as risk factors for recurrence in a survival analysis","volume":"14","author":"Aleixo","year":"2019","journal-title":"PLoS One"},{"key":"2025090109500776000_9.1.e001769.12","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.842595","article-title":"Toxoplasma gondii Genotyping: A Closer Look Into Europe","volume":"12","author":"Fern\u00e1ndez-Escobar","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090109500776000_9.1.e001769.13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01271","article-title":"EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System","volume":"10","author":"van Dongen","year":"2019","journal-title":"Front Immunol"},{"key":"2025090109500776000_9.1.e001769.14","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J Clin Immunol"},{"key":"2025090109500776000_9.1.e001769.15","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21162"},{"key":"2025090109500776000_9.1.e001769.16","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2025090109500776000_9.1.e001769.17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cei\/uxac103","article-title":"A close-up on the expanding landscape of CD21-\/low B cells in humans","volume":"210","author":"Gjertsson","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"2025090109500776000_9.1.e001769.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-022-05506-1","article-title":"Tim-3 downregulation by Toxoplasma gondii infection contributes to decidual dendritic cell dysfunction","volume":"15","author":"Xie","year":"2022","journal-title":"Parasit Vectors"},{"key":"2025090109500776000_9.1.e001769.19","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2018.1518102"},{"key":"2025090109500776000_9.1.e001769.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI135460"},{"key":"2025090109500776000_9.1.e001769.21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fcimb.2019.00136","article-title":"Toxoplasma gondii: CD8 T Cells Cry for CD4 Help","volume":"9","author":"Khan","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"2025090109500776000_9.1.e001769.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015298108"},{"key":"2025090109500776000_9.1.e001769.23","doi-asserted-by":"publisher","DOI":"10.1007\/S12016-021-08860-7"},{"key":"2025090109500776000_9.1.e001769.24","unstructured":"Surgical Neurology International . Cerebral toxoplasmosis in a patient with combined variable immunodeficiency. Available: https:\/\/surgicalneurologyint.com\/surgicalint-articles\/cerebral-toxoplasmosis-in-a-patient-with-combined-variable-immunodeficiency\/ [Accessed 23 Dec 2023]."},{"key":"2025090109500776000_9.1.e001769.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0224-6"},{"key":"2025090109500776000_9.1.e001769.26","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"key":"2025090109500776000_9.1.e001769.27","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2215\/CJN.0000000000000185","article-title":"Pathogenic Gene Spectrum and Clinical Implication in Chinese Patients with Lupus Nephritis","volume":"18","author":"Zhang","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025090109500776000_9.1.e001769.28","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-024-01685-x","article-title":"Germline HAVCR2\/TIM-3 Checkpoint Inhibitor Receptor Deficiency in Recurrent Autoinflammatory Myocarditis","volume":"44","author":"Pernaa","year":"2024","journal-title":"J Clin Immunol"},{"key":"2025090109500776000_9.1.e001769.29","doi-asserted-by":"crossref","DOI":"10.1007\/s10875-024-01667-z","article-title":"Post-transplant Inflammatory Bowel Disease Associated with Donor-Derived TIM-3 Deficiency","volume":"44","author":"Baldrich","year":"2024","journal-title":"J Clin Immunol"},{"key":"2025090109500776000_9.1.e001769.30","doi-asserted-by":"publisher","DOI":"10.1016\/J.CHOM.2022.10.001\/ATTACHMENT\/E22B770D-696D-4A98-818B-D31620E2C158\/MMC3.XLSX"},{"key":"2025090109500776000_9.1.e001769.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00203-014-0952-8"},{"key":"2025090109500776000_9.1.e001769.32","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01145-12"},{"key":"2025090109500776000_9.1.e001769.33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14209","article-title":"A human immunodeficiency syndrome caused by mutations in CARMIL2","volume":"8","author":"Schober","year":"2017","journal-title":"Nat Commun"},{"key":"2025090109500776000_9.1.e001769.34","doi-asserted-by":"crossref","first-page":"589604","DOI":"10.3389\/fmicb.2020.589604","article-title":"The Host Autophagy During Toxoplasma Infection","volume":"11","author":"Wu","year":"2020","journal-title":"Front Microbiol"},{"key":"2025090109500776000_9.1.e001769.35","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13170","article-title":"Advances in CD247","volume":"96","author":"Dexiu","year":"2022","journal-title":"Scand J Immunol"},{"key":"2025090109500776000_9.1.e001769.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0029-z"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-001769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:50:18Z","timestamp":1756745418000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-001769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,13]]},"published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1136\/bmjophth-2024-001769"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-001769","relation":{},"ISSN":["2397-3269"],"issn-type":[{"type":"electronic","value":"2397-3269"}],"subject":[],"published":{"date-parts":[[2024,9]]}}}